Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,443
Closed -$418K 1304
2026
Q1
$418K Sell
10,443
-3,597
-26% -$170K ﹤0.01% 673
2025
Q4
$631K Sell
14,040
-1,210
-8% -$56K ﹤0.01% 499
2025
Q3
$678K Buy
+15,250
New +$730K ﹤0.01% 426
2025
Q2
Sell
-6,086
Closed -$244K 874
2025
Q1
$244K Buy
+6,086
New +$256K ﹤0.01% 522

Other funds holding QGEN

Marex Group's QGEN Position: Q2 2026 in Review

Marex Group sold out of Qiagen (QGEN) in Q2 2026, closing a stake of 10,443 shares — an estimated $418K sold.

Marex Group first reported a position in QGEN in Q1 2025 and held it in 4 quarters. The position peaked at $678K in Q3 2025. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Marex Group reported no remaining Qiagen position as of Q2 2026 after selling out during the quarter.
  • Marex Group sold 10,443 Qiagen shares in Q2 2026, an estimated $418K.
  • Marex Group first reported a position in Qiagen in Q1 2025 and held it in 4 quarters.
  • Marex Group's Qiagen position peaked at $678K in Q3 2025.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.